United Therapeutics | UTHR - Sales Revenues

United Therapeutics reported $614.7M in Sales Revenues for its fiscal quarter ending in December of 2023.

Sales Change Date
Amarin USD 74.71M 8.66M Dec/2023
Ardelyx USD 34.36M 22.03M Dec/2023
Baxter International USD 3.88B 177M Dec/2023
Bayer EUR 11.86B 1.52B Dec/2023
Biogen USD 2.29B 96.3M Mar/2024
BioMarin Pharmaceutical USD 649M 2.79M Mar/2024
Gilead Sciences USD 7.12B 64M Dec/2023
GlaxoSmithKline GBP 8.05B 95M Dec/2023
Halozyme Therapeutics USD 230.04M 14.01M Dec/2023
Insmed USD 83.69M 4.62M Dec/2023
Intra Cellular Therapies USD 132.1M 5.93M Dec/2023
Ionis Pharmaceuticals USD 325M 180.79M Dec/2023
J&J USD 21.38B 15M Mar/2024
Moderna USD 2.81B 980M Dec/2023
Pfizer USD 14.25B 1.02B Dec/2023
PTC Therapeutics USD 210.12M 96.94M Mar/2024
Regeneron Pharmaceuticals USD 3.43B 71.6M Dec/2023
Sarepta Therapeutics USD 396.78M 64.96M Dec/2023
Teva Pharmaceutical Industries USD 4.46B 607M Dec/2023
United Therapeutics USD 614.7M 5.3M Dec/2023
Vertex Pharmaceuticals USD 2.52B 34.2M Dec/2023